Surprisingly, we observed that unilateral microinjection of a μOR-specific agonist, DAMGO, in the NTS led to the formation of the AT1R/μOR heterodimer, and that TLR4 expression was involved in the progression of hypertension. Here, TLR4 is linked to hypertensive disorder.